JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1373.0
  • -9.5-0.69%
20min DelayTrading Feb 18 09:05 JST
476.49BMarket Cap18.97P/E (Static)

Santen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Santen Pharmaceutical Q3 2025 Earnings Date

Currency：USDFeb 6, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
486.85M
--
-10.87%
EPS
--
0.16
--
+9.83%
Analyst Rating
Buy

Feb 6, 2025

Santen Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 72.500B--
--2025/Q4-- / 80.232B--
Feb 6, 20252025/Q376.369B / 75.285B--
Nov 7, 20242025/Q271.633B / 74.047B--
Aug 6, 20242025/Q174.771B / 73.939B--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 72.500B--
--2025/Q4-- / 80.232B--
Feb 6, 20252025/Q376.369B / 75.285B--
Nov 7, 20242025/Q271.633B / 74.047B--
Aug 6, 20242025/Q174.771B / 73.939B--

Unlock Free Earnings Estimates

Santen Pharmaceutical Earnings Reports

  • Santen Pharmaceutical: Notice regarding revisions to dividend forecasts

    Feb 6 01:00 ET

  • Santen Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [IFRS] (consolidated)

    Feb 6 01:00 ET

  • Santen Pharmaceutical: Confirmation letter

    Nov 11, 2024 01:32 ET

  • Santen Pharmaceutical: Half-Yearly Report - Term 113 (2024/04/01 - 2025/03/31)

    Nov 11, 2024 01:30 ET

    • Read more

    Trending Stocks

    Heat List Heat List
    No. Symbol Price
    Remixpoint
    3825
    712
    Sanrio
    8136
    7191.0
    Nippon Telegraph & Telephone
    9432
    148.0
    4
    Kioxia Holdings
    285A
    2122
    5
    Metaplanet
    3350
    6010
    Log In for the Full List
    Unlock Now